View Single Post
Old 03-13-2004, 02:48 PM   #1
Paul
Guest
 
Posts: n/a
According to results presented at the 2003 San Antonio Breast Cancer Symposium the investigational agent Abraxane™ (ABI-007) produced higher response rates and improved time to cancer progression compared to Taxol® in metastatic breast cancer.

  Reply With Quote